Enanta Pharmaceuticals Inc. (ENTA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Enanta Pharmaceuticals In...

NASDAQ: ENTA · Real-Time Price · USD
10.33
0.00 (0.00%)
At close: Oct 03, 2025, 3:59 PM
10.35
0.19%
After-hours: Oct 03, 2025, 07:25 PM EDT

Enanta Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
37.23M 85.39M 43.99M 57.21M
Short-Term Investments
210.95M 284.52M 205.24M 186.8M
Long-Term Investments
3.36M 3.97M 29.29M 108.42M
Other Long-Term Assets
94K 803K -516K -1.37M
Receivables
38.65M 39.62M 49.04M 60.83M
Inventory
n/a n/a n/a n/a
Other Current Assets
608K n/a n/a n/a
Total Current Assets
299.85M 422.79M 311.71M 319.02M
Property-Plant & Equipment
73.35M 34.71M 29.75M 10.65M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
76.8M 39.48M 63.7M 119.77M
Total Assets
376.65M 462.27M 375.41M 438.79M
Account Payables
8M 4.1M 6M 9.54M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
34.46M 35.08M 2.89M 4.2M
Other Current Liabilities
n/a n/a -2.89M -4.2M
Total Current Liabilities
57.53M 62.79M 29.83M 36.17M
Long-Term Debt
136.13M 160.85M 1.42M 1.51M
Other Long-Term Liabilities
231K 663K 454K 558K
Total Long-Term Liabilities
190.3M 182.75M 24.25M 3.19M
Total Liabilities
247.84M 245.54M 54.08M 39.36M
Total Debt
226.06M 26.51M 25.26M 5.33M
Book Value
128.81M 216.74M 321.33M 399.43M
Book Value Per Share
6.09 10.34 15.60 19.80
Common Stock
212K 211K 208K 202K
Retained Earnings
-323.04M -207M -73.18M 48.58M
Comprehensive Income
302K -1.17M -3.72M -382K
Shareholders Equity
128.81M 216.74M 321.33M 399.43M
Total Investments
210.95M 284.52M 234.52M 295.21M